Cover Image

Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines

Saved in:

Bibliographic Details
Main Authors:	Aneta Lipińska (Author), Maciej Pomorski (Author), Wojciech Matusewicz (Author), Katarzyna Jagodzińska-Kalinowska (Author)
Format:	Book
Published:	Taylor & Francis Group, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determining the prices of the medicines in the absence of superiority over alternative medical technology
by: Wojciech Matusewicz, et al.
Published: (2015)

Reimbursement process of medicinal products in Poland and in the world
by: Aneta Katarzyna Mela
Published: (2020)

Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
by: Hans-Georg Eichler, et al.
Published: (2023)

Stratified Medicine and Reimbursement Issues
by: Hans-Joerg eFugel, et al.
Published: (2012)

Medicines pricing and reimbursement in Canada
by: Chris BONNETT, et al.
Published: (2022)

Medicines Compliance and Reimbursement Level in Portugal
by: Maria da Conceição Constantino Portela, et al.
Published: (2015)

Medicines regulation, pricing and reimbursement in Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Expenditures on sugar-sweetened beverages in Jamaica and its association with household budget allocation
by: Guillermo Paraje, et al.
Published: (2022)

Reimbursement decision-making system in Poland systematically compared to other countries
by: Aneta Mela, et al.
Published: (2023)

Medicines pricing and reimbursement: innovation, competitiveness, and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Analysis of different categories of feedback in two organizational ways in gymnastics
by: M. Vernetta, et al.
Published: (2010)

A pain relieving reimbursement program? Effects of a value-based reimbursement program on patient reported outcome measures
by: Thérèse Eriksson, et al.
Published: (2020)

Italy - a study case of medicines pricing and reimbursement
by: Valdete A. MELO, et al.
Published: (2022)

Impact of delisting OTC medicines from reimbursement list
by: Petra Chytilová, et al.
Published: (2015)

Variation in expenditure for common, high cost surgical procedures in a working age population: implications for reimbursement reform
by: W. Wynn-Jones, et al.
Published: (2019)

Measuring financial protection against catastrophic health expenditures: methodological challenges for global monitoring
by: Justine Hsu, et al.
Published: (2018)

Correction to: A pain relieving reimbursement program? Effects of a value-based reimbursement program on patient reported outcome measures
by: Thérèse Eriksson, et al.
Published: (2020)

Emergency centre triage category allocations and their associated patient flow timeframes in a private healthcare group in the Middle East
by: Enrico Dippenaar
Published: (2019)

Resource Allocation Efficiency of Urban Medical and Health Financial Expenditure Under the Background of Employees’ Health
by: Gong C, et al.
Published: (2023)

Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
by: Rossen M Kazakov, et al.
Published: (2015)

Budget impact of publicly reimbursed prescription medicines in The Republic of Srpska
by: Tamara ePetrusic, et al.
Published: (2015)

Retrospective financial analysis of medicines reimbursement services in community pharmacy
by: Elena Chitan
Published: (2015)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
by: Agnes Vitry
Published: (2015)

Reimbursement measures in European countries - findings of a bibliometric literature review
by: Sabine Vogler, et al.
Published: (2015)

What is the impact of national public expenditure and its allocation on neonatal and child mortality? A machine learning analysis
by: Leandro Pereira Garcia, et al.
Published: (2023)

Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
by: Andreja Detiček, et al.
Published: (2018)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
by: Tomas Tesar, et al.
Published: (2021)

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries
by: Juan Carlos Rejon-Parrilla, et al.
Published: (2023)

Benefits of emergency department routine blood test performance on patients whose allocated triage category is not time critical: a retrospective study
by: Abdi D. Osman, et al.
Published: (2024)

Didactic exercises. A way to improve the simple direct attacks in the karatecas of the school category.
by: Yanet Castillo-Corbacho, et al.
Published: (2018)

Study on the ways of optimizing the physical training for the sports dance practitioners, juniors 2 category
by: Roșa Alin Cristian
Published: (2020)

The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
by: Féline E. V. Scheijmans, et al.
Published: (2022)

Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
by: E. Petro, et al.
Published: (2024)

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
by: Krzysztof Piotr Malinowski, et al.
Published: (2018)

Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries
by: Friele Roland, et al.
Published: (2010)

The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure
by: Anna Lukačišinová, et al.
Published: (2015)

Catastrophic expenditure on medicines in Brazil
by: Vera Lucia Luiza, et al.

Chemical analysis of wastewater as a new way of monitoring drugs and medicines consumption at workplace
by: Marek Wiergowski, et al.
Published: (2015)

On the Measurement of Financial Protection: An Assessment of the Usefulness of the Catastrophic Health Expenditure Indicator to Monitor Progress Towards Universal Health Coverage
by: Karen A. Grépin, et al.
Published: (2020)